AbbVie vs IBM: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. IBM was founded in 1911 by Charles Ranlett Flint and is led by Arvind Krishna.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
IBM
Charles Ranlett Flint
IBM possesses the most historic, foundational founding story in the entire history of modern computing, tracing its corporate lineage back to the genesis of data processing in the late 19th century and the aggressive, well-known leadership of a single, strong…
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
IBM
- Louis V. Gerstner Jr.1993–2002
Chairman and CEO
Gerstner was the first IBM CEO hired from outside the company, coming from RJR Nabisco and American Express. He cut costs, cut mainframe prices, kept the company whole, and grew services into IBM's largest business.
Source - Samuel J. Palmisano2002–2011
Chairman, President and CEO
IBM focused on higher-margin services and software during his tenure. Ginni Rometty succeeded him in 2012.
Source - Virginia M. Rometty2012–2020
Chairman, President and CEO
IBM sold or exited lower-margin businesses under Rometty and bought Red Hat for about $34 billion. Arvind Krishna succeeded her in 2020.
Source - James J. Kavanaugh2018–present
Senior Vice President, Finance and Operations, and Chief Financial Officer
Kavanaugh is IBM's main voice on free cash flow targets, which reached $14.7 billion in FY2025.
Source - Arvind Krishna2020–present
Chairman and CEO
Krishna, a long-time IBM Research and software executive, led the Red Hat acquisition before becoming CEO.
Source
Timeline: AbbVie and IBM side by side
1911IBM
Computing-Tabulating-Recording Company Founded
Charles Ranlett Flint merged the Tabulating Machine Company, International Time Recording Company, Computing Scale Company, and Bundy Manufacturing Company to form CTR - the company that would become IBM.
1924IBM
Renamed to International Business Machines
Under Thomas J. Watson Sr. CTR was renamed International Business Machines Corporation (IBM), reflecting the company's growing international presence and ambition beyond tabulating machines.
1952IBM
IBM 701 - First Commercial Computer
IBM launched the 701, its first commercially available electronic computer, marking the company's decisive entry into the electronic computing era and beginning its dominance of the mainframe market.
1964IBM
System/360 Launch
IBM launched the System/360, a compatible family of computers spanning all price points. The $5 billion investment was the largest privately funded project at the time and established the mainframe industry standard for decades.
1981IBM
IBM Personal Computer Launch
IBM introduced the IBM PC, which standardized personal computing architecture and created the PC industry. The open architecture decision inadvertently created the Wintel duopoly that would ultimately commoditize IBM's own PC business.
1993IBM
Lou Gerstner Arrives - Turnaround Begins
Louis V. Gerstner Jr. Became CEO as IBM posted $8 billion in losses. His decision to keep IBM intact rather than break it up, and to pivot toward services, saved the company and redefined its business model for the next two decades.
1997IBM
Deep Blue Defeats Kasparov
IBM's Deep Blue supercomputer defeated world chess champion Garry Kasparov, becoming the first computer to beat a reigning world champion in a full match and establishing IBM's brand in artificial intelligence.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2019IBM
Red Hat Acquisition Closes
IBM completed the $34 billion acquisition of Red Hat, the largest software acquisition in history at the time. The deal anchored IBM's hybrid cloud strategy and provided the OpenShift platform as the foundation for enterprise Kubernetes.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021IBM
Kyndryl Spinoff
IBM spun off its managed infrastructure services business as Kyndryl Holdings, removing approximately $19 billion in low-margin revenue to focus the remaining company on higher-margin software and consulting.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023IBM
Watsonx Platform Launch
IBM launched watsonx, its enterprise AI and data platform combining foundation models (Granite), data management (watsonx.data), and AI governance (watsonx.governance). The platform represents IBM's AI strategy for the generative AI era.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026IBM
Confluent Acquisition Closes
IBM completed its roughly $11 billion acquisition of Confluent, adding real-time data streaming used by more than 6,500 enterprises to its AI and hybrid cloud software.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
IBM
- Confluent2026$11B
- HashiCorp2025$6.4B
- Apptio2023$4.6B
- Red Hat2019$34B
- PricewaterhouseCoopers Consulting2002$3.5B
- Lotus Development Corporation1995$3.5B
Questions about AbbVie vs IBM
Who is the CEO of AbbVie Inc. and International Business Machines Corporation?
AbbVie Inc. is led by Robert A. Michael and International Business Machines Corporation is led by Arvind Krishna. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs International Business Machines Corporation?
International Business Machines Corporation was founded in 1911 — 102 years before AbbVie Inc., which was founded in 2013. International Business Machines Corporation's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to International Business Machines Corporation?
AbbVie Inc. employs approximately 57,000 people, while International Business Machines Corporation employs approximately 264,300. International Business Machines Corporation has the larger workforce at 264,300 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and International Business Machines Corporation headquartered?
Both AbbVie Inc. and International Business Machines Corporation are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and International Business Machines Corporation?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). International Business Machines Corporation was founded by Charles Ranlett Flint.
Which company has a longer operating history — AbbVie Inc. or International Business Machines Corporation?
International Business Machines Corporation has been operating for approximately 115 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs IBM overview